A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.

Clinical trial NCT07340424 · RECRUITING

Trial details

NCT number: NCT07340424
Sponsor: Xiaorong Sun
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Metastatic Triple-negative Breast Cancer (mTNBC)

Start date: 2025-05-22
Primary completion: 2027-04-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.